宁泌泰联合左氧氟沙星治疗慢性前列腺炎的临床疗效

Clinical efficacy of Ningmitai combined with levofloxacin in the treatment of chronic prostatitis

目的探讨宁泌泰联合左氧氟沙星治疗慢性前列腺炎的临床疗效。方法选取2015年2月至2017年2月于本院就诊的慢性前列腺炎患者110例,根据其意愿将其分为研究组和对照组,各55例。研究组给予宁泌泰联合左氧氟沙星治疗,对照组给予单纯左氧氟沙星治疗。比较两组患者的NIH-CPSI、SAS评分和不良反应发生率。结果治疗后,两组患者的NIH-CPSI评分及SAS评分均降低,且研究组低于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论左氧氟沙星联合宁泌泰治疗慢性前列腺炎,疗效显著,且不会增加不良反应发生率。联合用药可以明显改善患者的临床症状,降低患者焦虑感,能较快地改善炎症反应,对促进患者康复具有重要的意义,值得在临床上推广应用。

Objective To investigate the clinical curative effect of Ningmitai combined with levofloxacin in the treatment of chronic prostatitis. Methods From February 2015 to February 2017, 110 cases of patients with chronic prostatitis in our hospital were selected. According to their wishes, they were divided into study group and control group, with 55 cases in each group. The study group was given Ningmitai combined with levofloxacin treatment, and the control group was treated with levofloxacin alone. The NIH-CPSI, SAS scores and the incidences of adverse reactions were compared between the two groups. Results After treatment, the NIH-CPSI scores and SAS scores decreased in both groups, and those of the study group were lower than the control group(P<0.05). There was no significant difference in the incidences of adverse reactions between the two groups(P >0.05). Conclusion In the treatment of chronic prostatitis, levofloxacin combined with Ningmitai has significant effect, and does not increase the incidence of adverse reactions. It can improve the clinical symptoms, and reduce patients' anxiety, which has great significance to promote the rehabilitation of patients,and is worthy of clinical application.